Edition:
United States

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

23.22CNY
15 Dec 2017
Change (% chg)

¥-0.69 (-2.89%)
Prev Close
¥23.91
Open
¥23.81
Day's High
¥23.84
Day's Low
¥23.11
Volume
4,311,958
Avg. Vol
6,220,112
52-wk High
¥25.15
52-wk Low
¥18.02

Chart for

About

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly... (more)

Overall

Beta: 0.69
Market Cap(Mil.): ¥20,169.26
Shares Outstanding(Mil.): 869.36
Dividend: 0.08
Yield (%): 0.36

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

BRIEF-China Resources Double-Crane Pharmaceutical's 9-month net profit up 20.5 pct y/y

Oct 24 China Resources Double-Crane Pharmaceutical Co Ltd

Oct 24 2017

BRIEF-China Resources Double-Crane Pharmaceutical receives GMP certificate

Aug 30China Resources Double-Crane Pharmaceutical Co Ltd

Aug 30 2017

BRIEF-China Resources Double-Crane Pharmaceutical's H1 net profit up 20.1 pct y/y

Aug 17 China Resources Double-Crane Pharmaceutical Co Ltd

Aug 17 2017

BRIEF-China Resources Double-Crane Pharmaceutical receives GMP certificate

July 7 China Resources Double-Crane Pharmaceutical Co Ltd :

Jul 07 2017

Earnings vs. Estimates